839 results found.
CartiHeal Initiates Agili-C Implant IDE Multinational Pivotal Study
CartiHeal enrolled and treated 16 patients in its IDE study of Agili-C™ implants in the...
OrthoPediatrics Launches IPO
OrthoPediatrics launched its initial public offering of 4MM shares of common stock, with a proposed offering price of $12-$14/share...
Subchondral Solutions Receives FDA Clearance for Fenestrated Cannulated Screws
Subchondral Solutions received FDA 510(k) clearance to market the fenestrated, cannulated S4 Screw System&trade...
Mortise Medical Receives FDA Clearance for LigaMetrics Suture Anchor
Mortise Medical received FDA 510(k) clearance to market the LigaMetrics™ Suture Anchor ...
MiMedx Can Launch Phase 3 IND Trial for Achilles Tendonitis
MiMedx received permission to proceed with an Investigational New Drug Phase III clinical trial of AmnioFix® ...
Orthocell Recruits First Patient for Ortho-ATI Shoulder Tendon Study
Orthocell announced recruitment of the first patient in a clinical trial investigating Ortho-ATI
OrthoPediatrics Files to Raise $57.5MM in an IPO
OrthoPediatrics plans to raise US $57.5MM in a proposed initial public offering. 
Ziptek Furthers Patent Protection for Resorbable Knotless Tissue Repair
Within 2017, Ziptek received notice of allowance for four patents related to ZipE® resorbable knotless t...
Strategic Orthopaedic-related 510(k)s Issued in July 2017: Interbody Focus
Strategic orthopaedic-related 510(k)s issued in July 2017 include: EIT Cellular Titanium Cages (EIT Emerging Implant Technologies), Lumbar Interb...
Active Implants Enrolls 100 Patients in NUsurface Trial
Active Implants enrolled the 100th patient in clinical trials evaluating the NUsurface® Meniscu...
Study Results: Anika's HYALOFAST in Knee Cartilage Lesions
Studies indicate that Anika Therapeutics' HYALOFAST® scaffold + autologous adult MSCs present a viable option to treat knee ca...
MiMedx Files for Achilles Tendonitis IND Phase III Clinical Trial
MiMedx filed to initiate an Investigational New Drug Phase III clinical study comparing AmnioFix® I...
Wright Medical 2Q17 Revenue
Wright Medical reported 2Q17 revenue of US $179.7MM, +5.3% from 2Q16, and 1H17 revenue of $356.9MM, +5.0% vs. 1H16.
Smith & Nephew 2Q17 Orthopaedic Revenue
ORTHOWORLD estimates Smith & Nephew 2Q17 orthopaedic revenue of US $834.0MM, +1.1% from 2Q16, and 1H17 revenue of $1,660.9MM, +2.0%
Stryker Reports 2Q17 Revenue
ORTHOWORLD estimates Stryker’s 2Q17 orthopaedic revenue at US $1,618.7MM, +4.0% from 2Q16, and 1H17 revenue of $3,230.9MM, +4.9%
Zimmer Biomet Orthopaedic Revenue for 2Q17
ORTHOWORLD estimates Zimmer Biomet 2Q17 orthopaedic revenue of US $1,816.0MM, +2.6% from 2Q16, and 1H17 revenue of $3,652.1MM, ...
ConMed Reports 2Q17 Revenue
ConMed posted 2Q17 arthroscopy/soft tissue repair revenue of US $105.5MM, -0.3% vs. 2Q16.
Tissue Regenix Proposes Acquisition of CellRight Technologies
Tissue Regenix proposes to acquire CellRight Technologies for US $30MM, to offer products for bone and soft ...
DePuy Synthes 2Q17 Orthopaedic Revenue
ORTHOWORLD estimates DePuy Synthes’ 2Q17 orthopaedic revenue at US $2,214.8MM, +0.4% vs. 2Q16.
DePuy Synthes Company Profile
We're redesigning Company Profiles. To get the most current news and articles about DePuy Synthes in the interim,
Smith & Nephew, Imperial College to Study Meniscus Function
Smith & Nephew signed a 3-year partnership with Imperial College London to study meniscus function and d...
Clinical Trial of Stem Cells to Treat Massive Knee Cartilage Injury
A 6-year, randomized clinical trial is underway to evaluate use of a patient's own stem cells to regenerate knee cartila...
MedShape Divests ACL Fixation Products to ConMed
MedShape reached a definitive agreement for ConMed to acquire the ExoShape® ACL fixation system
Study Results Indicate Rotator Cuff Function and Pain Improve with Use of InSpace
Study results indicated 37 patients demonstrated improved rotator cuff function and pain after ...
Histogenics Completes Enrollment for NeoCart Phase III Clinical Trial
Histogenics completes enrollment of 245 patients in its NeoCart Phase III clinical trial.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2018 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group